GE Healthcare's $2.3 Billion Takeover Is a Bold Growth Play. Here's Why. -- Barrons.com

Dow Jones
Nov 22, 2025

Al Root

GE Healthcare Technologies is trying to kick-start growth, which should please investors.

The medical imaging and diagnostic company announced on Thursday an agreement to acquire Intelerad, a medical imaging software provider with a presence in outpatient ambulatory care, for $2.3 billion in cash.

The deal should close in the first half of 2026.

The deal complements GE HealthCare's inpatient footprint. "The combined business will broaden customer reach and [deliver] a comprehensive, integrated imaging solution across multiple care settings," said the company in a news release. "In addition, Intelerad's business model accelerates GE HealthCare's shift towards a [software as a service], SaaS, model and significantly increases recurring revenue."

It is GE Healthcare's first acquisition since its separation from GE in January 2023, pointed out Citi analyst Joanne Wuensch in a Thursday report. "The transaction will be immediately accretive to top-line growth and adjusted [operating profit] margin, though slightly dilutive to adjusted earnings per share in the short term," she said. Wuensch rates GE Healthcare stock Hold and has an $83 price target for shares.

Revenue in the first full year of ownership should be about $270 million, said the company. Earnings before interest, taxes, depreciation, and amortization, or Ebitda, margins are "in excess of 30%." GE Healthcare is expected to produce a 2025 Ebitda margin of almost 18% from sales of about $20.5 billion.

Investors don't seem to mind the dilution. Shares rose 2.3% on Friday, closing at $76.45, while the S&P 500 and Dow Jones Industrial Average gained 1% and 1.1%, respectively. Friday's gain for GE Healthcare stock followed a 3.4% jump on Thursday.

Coming into Friday trading, GE Healthcare's stock was down 4% so far this year and down 12% over the past 12 months.

Tariffs and trade concerns have weighed on investor sentiment and on Wall Street's forecasts of profits. GE Healthcare is expected to make about $4.55 per share in 2025. That estimate was closer to $4.70 a year ago.

GE Healthcare earned about $4.50 in 2024, so earnings growth has been slow lately.

Write to Al Root at allen.root@dowjones.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 21, 2025 16:19 ET (21:19 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10